1563-86-6 Usage
Uses
Used in Adhesives Industry:
N-acetyl-N-butylacetamide is used as a plasticizer to enhance the flexibility and durability of adhesives, making them more effective in bonding various materials.
Used in Sealants Industry:
N-acetyl-N-butylacetamide is used as a plasticizer in sealants to improve their performance and flexibility, ensuring a better seal and longer-lasting results.
Used in Coatings Industry:
N-acetyl-N-butylacetamide is used as a plasticizer in coatings to increase their durability and flexibility, providing a longer-lasting and more robust finish.
Used as a Solvent:
N-acetyl-N-butylacetamide is used as a solvent in various formulations, helping to dissolve and mix different substances effectively.
Used as a Viscosity-Adjusting Agent:
N-acetyl-N-butylacetamide is used to adjust the viscosity of different formulations, ensuring optimal consistency and performance.
It is important to handle N-acetyl-N-butylacetamide with caution, as it may present some health hazards if not properly managed.
Check Digit Verification of cas no
The CAS Registry Mumber 1563-86-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,5,6 and 3 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1563-86:
(6*1)+(5*5)+(4*6)+(3*3)+(2*8)+(1*6)=86
86 % 10 = 6
So 1563-86-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H15NO2/c1-4-5-6-9(7(2)10)8(3)11/h4-6H2,1-3H3
1563-86-6Relevant articles and documents
Comparison of the hypolipidemic activity of cyclic vs. acyclic imides
Voorstad,Chapman,Cocolas,Wyrick,Hall
, p. 9 - 12 (2007/10/02)
Two series of nitrogen-substituted cyclic and acyclic imides were examined for hypolipidemic activity in mice after dosing for 16 days at a dose of 20 mg/kg per day. The hypolipidemic activity of the unsubstituted, N-butyl, N-3-oxobutyl, and N-2-carboxyethyl derivatives of diacetimide and succinimide were compared as well as the unsubstituted and N-substituted dibenzimide and diphenimide. It was shown that an imide functionally incorporated into a ring was not necessary for hypocholesterolemic activity. Good hypocholesterolemic activity was observed in both series of acyclic and cyclic imides. However, a cyclic imido structure was a necessary requirement for good hypotriglyceridemic activity. A decrease in hypotriglyceridemic activity was noted when comparing the cyclic imides to their respective acyclic congeners.
